Video
Grant Knowles, PharmD, vice president, Business Development, Ardon Health, discusses the potential impact biosimilars will have in health care.
Knowles: I think any time you introduce competition into an environment, there's a lot of opportunities for economic gains--they can be positive, they can be negative. I think it will be interested to watch to see as biosimilars are launched and see the traction with health plans and pharmacies.
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.